{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Lyophilized formulation of a monoclonal antibody against transthyretin", "item": "https://www.patentleaderboard.com/patent/11873332"}]}

Home › Lyophilized formulation of a monoclonal antibody against transthyretin

Lyophilized formulation of a monoclonal antibody against transthyretin

US Patent 11873332 · Granted Jan 16, 2024

Estimated economic value: $148,857,000 ⓘ

Assignee

Novo Nordisk A/S

Inventors

Joseph Alexander Soto (1 patents)
Andrea HAWE (5 patents)
Ruedeeporn Tantipolphan (1 patents)
Stefan Heindl (2 patents)

View full patent text on Google Patents →